Skip to main content

Akiram Therapeutics

The startup develops radiopharmaceuticals that utilize novel radioactive molecules for targeted imaging and treatment of solid tumors. By enhancing the visualization and therapeutic targeting of aggressive cancers, the company aims to improve diagnostic accuracy and treatment efficacy for oncologists.

Traction 8/10
Uppsala, Sweden · HQ
Founded 20214700+ followers
  • Biotechnology
Updated 23 months ago

Funding

Raised to date

$6.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Marika Nestor

CEO

Peder Walberg

Life science entrepreneur / investor / board member / advisor

Product

Features

  • The startup develops radiopharmaceuticals that utilize novel radioactive molecules for targeted imaging and treatment of solid tumors. By enhancing the visualization and therapeutic targeting of aggressive cancers, the company aims to improve diagnostic accuracy and treatment efficacy for oncologists.
This profile is AI-generated and may contain inaccuracies.